Johnson & Johnson
stock is rising in after-hours trading after the company announced a nearly $9 billion settlement over claims that its talcum powder causes cancer.
In a press release, Johnson & Johnson said that its subsidiary, LTL Management, would refile for bankruptcy protection and be funded with $8.9 billion over 25 years to cover talc liabilities.
Source: https://www.barrons.com/articles/jnj-stock-price-talc-cancer-14ee8132?siteid=yhoof2&yptr=yahoo